MyAverix Finance
SHG · Healthcare
RemeGen Co. Ltd. A (688331)
Biotechnology
RemeGen Co. Ltd. A (688331) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $69.64B, P/E ratio is 95.80, net margin is 21.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688331
RemeGen Co. Ltd. A (688331) — FAQ
What is RemeGen Co. Ltd. A's market cap?
RemeGen Co. Ltd. A (688331) has a reported market cap of $69.64B (data as of 2026-03-29).
What is 688331's P/E ratio?
The price-to-earnings (P/E) ratio for RemeGen Co. Ltd. A (688331) is 95.80 (data as of 2026-03-29).
Does RemeGen Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for RemeGen Co. Ltd. A (688331). Check the MyAverix Finance app for the latest dividend data.
What sector is RemeGen Co. Ltd. A in?
RemeGen Co. Ltd. A (688331) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688331 listed on?
688331 is listed on SHG.
What is RemeGen Co. Ltd. A's net margin?
RemeGen Co. Ltd. A (688331) reports a net margin of 21.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.